Met Life Investment Management, LLC X Biotech Inc. Transaction History

Met Life Investment Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$5.55 - $7.95 $67,471 - $96,648	12,157 New	12,157 $93,000
Q4 2021 Feb 15, 2022	SELL	$10.95 - $16.07 $64,517 - $94,684	-5,892 Closed	0 $0
Q3 2021 May 17, 2024	BUY	$12.95 - $18.24 $76,301 - $107,470	5,892 New	5,892 $76,000
Q3 2021 Jun 21, 2023	BUY	$12.95 - $18.24 $76,301 - $107,470	5,892 New	5,892 $76,000
Q3 2021 Mar 22, 2023	BUY	$12.95 - $18.24 $76,301 - $107,470	5,892 New	5,892 $76,000
Q3 2021 Nov 15, 2021	BUY	$12.95 - $18.24 $76,301 - $107,470	5,892 New	5,892 $76,000
Q3 2020 Jun 26, 2023	BUY	$13.97 - $21.16 $92,523 - $140,142	6,623 New	6,623 $126 Million
Q2 2020 May 24, 2024	BUY	$10.39 - $16.07 $68,812 - $106,431	6,623 New	6,623 $90.8 Million
Q2 2020 Jun 26, 2023	BUY	$10.39 - $16.07 $68,812 - $106,431	6,623 New	6,623 $90.8 Million
Q4 2019 Jul 12, 2023	BUY	$8.33 - $19.95 $77,535 - $185,694	9,308 New	9,308 $174 Million

4.9M

Ticker XBIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,439,300
Market Cap $97.7M
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Met Life Investment Management, LLC with notifications on news.